University of California San Francisco

dr-sandy-feng-md
Sandy Feng, MD, PhD

Professor of Surgery
Division of Transplant Surgery
Vice Chair for Research

UCSF DEI Champion badge

Address

505 Parnassus Avenue, #M896
San Francisco, CA 94117
United States

Email: [email protected]
Phone: 415-353-8725
Fax: 415-353-8709

ORCID: 0000-0002-2601-4350

Biography

Dr. Sandy Feng is a transplant surgeon who performs liver, kidney and pancreas transplants. In her research, Feng studies transplantation tolerance, a transplant recipient's ability to maintain normal organ function with minimal or no use of immunosuppressive drugs. With funding from the National Institutes of Health, she has led several multicenter clinical trials to study tolerance in both adult and pediatric liver transplant recipients. Feng is a graduate of Harvard College, where she received the prestigious Marshall Scholarship. She completed a doctorate in molecular biology at the University of Cambridge and earned her medical degree at Stanford University School of Medicine. She completed a general surgery residency at Brigham and Women's Hospital, followed by a transplant fellowship at UCSF. Feng has held leadership positions in prominent professional societies and with the United Network for Organ Sharing. She has organized several national conferences addressing issues critical to the transplantation community, serves on the editorial board of the New England Journal of Medicine and is the editor-in-chief for the American Journal of Transplantation.

Videos

Education

Institution Degree Dept or School End Date
University of California Diversity, Equity, and Inclusion Champion Training 12/2020
Stanford University M.D. School of Medicine 1990

Board Certifications

American Board of Surgery, 1996

Collaboration Interests

I am interested in:

  • PhysicianScientist

Clinical Expertise

Expanded Criteria Donor Kidney Transplantation
Immunosuppression for Liver Transplantation
Kidney Transplantation
Liver Transplantation
MELD Allocation and Living Donor Liver Transplantation
Pancreas Transplantation

Clinical Trials

  1. Expanding Liver Transplant Immunosuppression Minimization Via Everolimus (NCT06280950)
    Related Conditions: Liver Transplant| Start Date: | End Date:
  2. Liver Transplantation With Tregs at UCSF (NCT03654040)
    Related Conditions: Liver Transplant| Start Date: | End Date:
  3. Diagnostic and Therapeutic Applications of Microarrays in Liver Transplantation (NCT03193151)
    Related Conditions: Liver Disease, Liver Transplant| Start Date: | End Date:
  4. Donor Alloantigen Reactive Tregs (darTregs) for Calcineurin Inhibitor (CNI) Reduction (NCT02474199)
    Related Conditions: Liver Transplant| Start Date: | End Date:
  5. Donor-Alloantigen-Reactive Regulatory T Cell (darTregs) in Liver Transplantation (NCT02188719)
    Related Conditions: Liver Transplant| Start Date: | End Date:
  6. Withdrawal of Immunosuppression in Pediatric Liver Transplant Recipients (NCT00320606)
    Related Conditions: Liver Transplant| Start Date: | End Date:

Program Affiliations

  • Clinical Fellowship, Division of Transplantation
  • The Liver Center at UCSF
  • Director, Expanded Criteria Donor Kidney Transplant Program, University of California, San Francisco
  • UCSF Hellen Diller Family Comprehensive Cancer Center

Grants and Funding

  • PROSPECTIVE LONGITUDINAL STUDY OF IWITH SCREEN FAILURES SECONDARY TO HISTOPATHOLOGY | NIH | 2017-08-10 - 2021-07-31 | Role: Principal Investigator
  • Donor-Alloantigen-Reactive Regulatory T Cell Therapy in Liver Transplantation | NIH | 2014-06-01 - 2021-05-31 | Role: Principal Investigator
  • Polyclonal Tregs to Promote Tolerance in Pediatric Liver Transplant Recipients | NIH | 2013-02-01 - 2020-01-31 | Role: Principal Investigator
  • Immunosuppression Withdrawal for Stable Pediatric Liver Transplant Recipients | NIH | 2012-07-27 - 2019-06-30 | Role: Principal Investigator
  • Donor-Specific Regulatory T Cell Therapy in Liver Transplantation | NIH | 2012-04-01 - 2014-03-31 | Role: Principal Investigator
  • Immunosuppression Withdrawal for Stable Pediatric Liver Transplant Recipients | NIH | 2009-09-30 - 2013-03-31 | Role: Principal Investigator

Research Narrative

Dr. Feng's research interest focuses on transplant immunology, with a particular focus on determinants of organ tolerance. She is also investigating novel immunosuppressive regimens and pursuing immunosuppression withdrawal in selected liver transplant recipients. By studying the immune profiles of transplant patients who are successfully weaned from immunosuppressants, she and her group hope to predict prospectively which patients may be good candidates for immunosuppression withdrawal.

Research Interests

  • Immunosuppression Withdrawal for Stable Pediatric Living Donor Liver Transplant Recipients
  • Immunosuppression Withdrawal and Identification of a Profile Predictive of Tolerance
  • Defining the Optimal Immunosuppression for Specific Transplant Settings
  • Expanded Criteria Donors
  • Novel Immunosuppression Strategies for Liver Transplantation
  • Strategies to Decrease Ischemia Reperfusion Injury to Improve Early Graft Function after Kidney Transplantation
  • Improving Long-term Outcomes for Liver Transplant Recipients

Publications

MOST RECENT PUBLICATIONS FROM A TOTAL OF 131
  1. The future of Liver Transplantation.
    Feng S, Roll GR, Rouhani FJ, Sanchez Fueyo A| | View in PubMed
  2. Banff 2022 liver group meeting report: monitoring long term allograft health.
    Bellamy COC, O'Leary JG, Adeyi O, Baddour N, Batal I, Bucuvalas J, Del Bello A, El Hag M, El-Monayeri M, Farris AB, Feng S, Fiel MI, Fischer SE, Fung J, Grzyb K, Guimei M, Haga H, Hart J, Jackson AM, Jaeckel E, Khurram NA, Knechtle SJ, Lesniak D, Levitsky J, McCaughan G, McKenzie C, Mescoli C, Miquel R, Minervini MI, Nasser IA, Neil D, O'Neil MF, Pappo O, Randhawa P, Ruiz P, Fueyo AS, Schady D, Schiano T, Sebagh M, Smith M, Stevenson HL, Taner T, Taubert R, Thung S, Trunecka P, Wang HL, Wood-Trageser M, Yilmaz F, Zen Y, Zeevi A, Demetris AJ| | View in PubMed
  3. The Banff process-Reloaded: A joint initiative from the Banff Foundation for Allograft Pathology and the American Journal of Transplantation.
    Mengel M, Mannon RB, Feng S| | View in PubMed
  4. A modified hospital frailty risk score for patients with cirrhosis undergoing abdominal operations.
    Calthorpe L, Chiou SH, Rubin J, Huang CY, Feng S, Lai J| | View in PubMed
  5. Advancing mouse models for transplantation research.
    Cravedi P, Riella LV, Ford ML, Valujskikh A, Menon MC, Kirk AD, Alegre ML, Alessandrini A, Feng S, Kehn P, Najafian N, Hancock WW, Heeger PS, Maltzman JS, Mannon RB, Nadig SN, Odim J, Turnquist H, Shaw J, West L, Luo X, Chong AS, Bromberg JS, AST COTS MOuse MOdels in Transplantation (MOMOT) work group| | View in PubMed
  6. Transforming the Future of Surgeon-Scientists.
    Ladner DP, Goldstein AM, Billiar TR, Cameron AM, Carpizo DR, Chu DI, Coopersmith CM, DeMatteo RP, Feng S, Gallagher KA, Gillanders WE, Lal BK, Lipshutz GS, Liu A, Maier RV, Mittendorf EA, Morris AM, Sicklick JK, Velazquez OC, Whitson BA, Wilke LG, Yoon SS, Zeiger MA, Farmer DL, Hwang ES, ASA Task Force for Research Sustainability| | View in PubMed
  7. Time since liver transplant and immunosuppression withdrawal outcomes: Systematic review and individual patient data meta-analysis.
    Appenzeller-Herzog C, Rosat A, Mathes T, Baroja-Mazo A, Chruscinski A, Feng S, Herrero I, Londono MC, Mazariegos G, Ohe H, Pons JA, Sanchez-Fueyo A, Waki K, Vionnet J| | View in PubMed
  8. Kidney transplantation in a patient with anomalous iliofemoral vasculature.
    Dixon W, Sheetz K, Feng S| | View in PubMed
  9. DCD liver transplant in patients with a MELD over 35.
    Meier RPH, Nunez M, Syed SM, Feng S, Tavakol M, Freise CE, Roberts JP, Ascher NL, Hirose R, Roll GR| | View in PubMed
  10. Mapping children by ALT 4-5 years after liver transplant: Potential individual and population applications.
    Dixon W, Perito ER, Bucuvalas J, Feng S| | View in PubMed
  11. Novel autoantibody targets identified in patients with autoimmune hepatitis (AIH) by PhIP-Seq reveals pathogenic insights.
    Klepper A, Kung A, Vazquez SE, Mitchell A, Mann S, Zorn K, Avila-Vargas I, Kari S, Tekeste M, Castro J, Lee B, Duarte M, Khalili M, Yang M, Wolters P, Price J, Perito E, Feng S, Maher JJ, Lai J, Weiler-Normann C, Lohse AW, DeRisi J, Tana M| | View in PubMed
  12. Normothermic Machine Perfusion of Donor Livers for Transplantation in the United States: A Randomized Controlled Trial.
    Chapman WC, Barbas AS, D'Alessandro AM, Vianna R, Kubal CA, Abt P, Sonnenday C, Barth R, Alvarez-Casas J, Yersiz H, Eckhoff D, Cannon R, Genyk Y, Sher L, Singer A, Feng S, Roll G, Cohen A, Doyle MB, Sudan DL, Al-Adra D, Khan A, Subramanian V, Abraham N, Olthoff K, Tekin A, Berg L, Coussios C, Morris C, Randle L, Friend P, Knechtle SJ| | View in PubMed
  13. Real-world implementation of normothermic machine perfusion: A detailed analysis of intraoperative and early postoperative impact.
    Dixon W, Sheetz K, Adelmann D, Bokoch M, Reddy M, Kothari R, Roberts JP, Syed S, Feng S, Roll G| | View in PubMed
  14. Liver transplantation immunology: Immunosuppression, rejection, and immunomodulation.
    Montano-Loza AJ, Rodríguez-Perálvarez ML, Pageaux GP, Sanchez-Fueyo A, Feng S| | View in PubMed
  15. Supporting Robust Teamwork - Bridging Technology and Organizational Science.
    Mayo AT, Myers CG, Bucuvalas JC, Feng S, Juliano CE| | View in PubMed
  16. Immunosuppression after pediatric liver transplant: The parents' perspective.
    Batsis I, Bucuvalas J, Eisenberg E, Lau J, Squires JE, Feng S, Perito ER| | View in PubMed
  17. Addressing sex-based disparities in solid organ transplantation in the United States - a conference report.
    Sawinski D, Lai JC, Pinney S, Gray AL, Jackson AM, Stewart D, Levine DJ, Locke JE, Pomposelli JJ, Hartwig MG, Hall SA, Dadhania DM, Cogswell R, Perez RV, Schold JD, Turgeon NA, Kobashigawa J, Kukreja J, Magee JC, Friedewald J, Gill JS, Loor G, Heimbach JK, Verna EC, Walsh MN, Terrault N, Testa G, Diamond JM, Reese PP, Brown K, Orloff S, Farr MA, Olthoff KM, Siegler M, Ascher N, Feng S, Kaplan B, Pomfret E| | View in PubMed
  18. Selective decrease of donor-reactive Tregs after liver transplantation limits Treg therapy for promoting allograft tolerance in humans.
    Tang Q, Leung J, Peng Y, Sanchez-Fueyo A, Lozano JJ, Lam A, Lee K, Greenland JR, Hellerstein M, Fitch M, Li KW, Esensten JH, Putnam AL, Lares A, Nguyen V, Liu W, Bridges ND, Odim J, Demetris AJ, Levitsky J, Taner T, Feng S| | View in PubMed
  19. Next-generation pathology detection of T cell-antigen-presenting cell immune synapses in human liver allografts.
    Wood-Trageser MA, Lesniak D, Gambella A, Golnoski K, Feng S, Bucuvalas J, Sanchez-Fueyo A, Demetris AJ| | View in PubMed
  20. Standardizing the histological assessment of late posttransplantation biopsies from pediatric liver allograft recipients.
    Hübscher SG, Feng S, Gouw ASH, Haga H, Kang HJ, Kelly DA, Komuta M, Lesniak A, Popp BA, Verkade HJ, Yu E, Demetris AJ| | View in PubMed
  21. Transcriptomic profiling of blood from autoimmune hepatitis patients reveals potential mechanisms with implications for management.
    Tana MM, Klepper A, Lyden A, Pisco AO, Phelps M, McGee B, Green K, Feng S, DeRisi J, Crawford ED, Lammert CS| | View in PubMed
  22. Graft Fibrosis Over 10 to 15 Years in Pediatric Liver Transplant Recipients: Multicenter Study of Paired, Longitudinal Surveillance Biopsies.
    Perito ER, Persyn E, Bucuvalas J, Martinez M, Mohammad S, Squires JE, Demetris AJ, Feng S| | View in PubMed
  23. We Asked the Experts: Toward Personalized Immunosuppression for Liver Transplant Recipients.
    Lew J, Perito ER, Feng S| | View in PubMed
  24. Not everything that counts can be counted: Tracking long-term outcomes in pediatric liver transplant recipients.
    Cheng K, Feng S, Bucuvalas JC, Levitsky J, Perito ER| | View in PubMed
  25. Advantages and Limitations of Clinical Scores for Donation After Circulatory Death Liver Transplantation.
    Meier RPH, Kelly Y, Yamaguchi S, Braun HJ, Lunow-Luke T, Adelmann D, Niemann C, Maluf DG, Dietch ZC, Stock PG, Kang SM, Feng S, Posselt AM, Gardner JM, Syed SM, Hirose R, Freise CE, Ascher NL, Roberts JP, Roll GR| | View in PubMed
  26. Impact of Donor and Recipient Clinical Characteristics and Hepatic Histology on Steatosis/Fibrosis Following Liver Transplantation.
    Shaked O, Demetris J, Levitsky J, Feng S, Loza BL, Punch J, Reyes J, Klintmalm G, Jackson W, DesMarais M, Sayre P, Shaked A, Reddy KR| | View in PubMed
  27. Frailty, mortality, and health care utilization after liver transplantation: From the Multicenter Functional Assessment in Liver Transplantation (FrAILT) Study.
    Lai JC, Shui AM, Duarte-Rojo A, Ganger DR, Rahimi RS, Huang CY, Yao F, Kappus M, Boyarsky B, McAdams-Demarco M, Volk ML, Dunn MA, Ladner DP, Segev DL, Verna EC, Feng S, from the Multi-Center Functional Assessment in Liver Transplantation (FrAILT) Study| | View in PubMed
  28. The molecular phenotypes of injury, steatohepatitis, and fibrosis in liver transplant biopsies in the INTERLIVER study.
    Madill-Thomsen KS, Abouljoud M, Bhati C, Ciszek M, Durlik M, Feng S, Foroncewicz B, Francis I, Grat M, Jurczyk K, Klintmalm G, Krasnodebski M, McCaughan G, Miquel R, Montano-Loza A, Moonka D, Mucha K, Myslak M, Paczek L, Perkowska-Ptasinska A, Piecha G, Reichman T, Sanchez-Fueyo A, Tronina O, Wawrzynowicz-Syczewska M, Wiecek A, Zieniewicz K, Halloran PF| | View in PubMed
  29. Baby Steps: Understanding Allograft Fibrosis in Pediatric Liver Transplantation.
    Dixon W, Perito ER, Feng S| | View in PubMed
  30. Non-invasive alloimmune risk stratification of long-term liver transplant recipients.
    Vionnet J, Miquel R, Abraldes JG, Wall J, Kodela E, Lozano JJ, Ruiz P, Navasa M, Marshall A, Nevens F, Gelson W, Leithead J, Masson S, Jaeckel E, Taubert R, Tachtatzis P, Eurich D, Simpson KJ, Bonaccorsi-Riani E, Feng S, Bucuvalas J, Ferguson J, Quaglia A, Sidorova J, Elstad M, Douiri A, Sánchez-Fueyo A| | View in PubMed
  31. Efficacy and Safety of Immunosuppression Withdrawal in Pediatric Liver Transplant Recipients: Moving Toward Personalized Management.
    Feng S, Bucuvalas JC, Mazariegos GV, Magee JC, Sanchez-Fueyo A, Spain KM, Lesniak A, Kanaparthi S, Perito E, Venkat VL, Burrell BE, Alonso EM, Bridges ND, Doo E, Gupta NA, Himes RW, Ikle D, Jackson AM, Lobritto SJ, Jose Lozano J, Martinez M, Ng VL, Rand EB, Sherker AH, Sundaram SS, Turmelle YP, Wood-Trageser M, Demetris AJ| | View in PubMed
  32. Improvements in Disease-Specific Health-Related Quality of Life of Pediatric Liver Transplant Recipients During Immunosuppression Withdrawal.
    Mohammad S, Sundaram SS, Mason K, Lobritto S, Martinez M, Turmelle YP, Bucuvalas J, Feng S, Alonso EM| | View in PubMed
  33. Transplantation From Older Donors: Can Senolytics Turn Back the Clock?
    Dixon W, Feng S, Gardner J| | View in PubMed
  34. COVID-19 and Abdominal Transplant: A Stepwise Approach to Practice During Pandemic Conditions.
    Syed SM, Gardner J, Roll G, Webber A, Mehta N, Shoji J, Adelmann D, Niemann C, Braun HJ, Mello A, Yao F, Posselt A, Kang SM, Hirose R, Roberts J, Feng S, Ascher N, Stock P, Freise C| | View in PubMed
  35. A Virtual Crossmatch-based Strategy Facilitates Sharing of Deceased Donor Kidneys for Highly Sensitized Recipients.
    Roll GR, Webber AB, Gae DH, Laszik Z, Tavakol M, Mayen L, Cunniffe K, Syed S, Hirose R, Freise C, Feng S, Roberts JP, Ascher NL, Stock PG, Rajalingam R| | View in PubMed
  36. Sensitization in transplantation: Assessment of risk (STAR) 2019 Working Group Meeting Report.
    Tambur AR, Campbell P, Chong AS, Feng S, Ford ML, Gebel H, Gill RG, Kelsoe G, Kosmoliaptsis V, Mannon RB, Mengel M, Reed EF, Valenzuela NM, Wiebe C, Dijke IE, Sullivan HC, Nickerson P| | View in PubMed
  37. Rapid Modification of Workflows and Fellow Staffing at a Single Transplant Center to Address the COVID-19 Crisis.
    Thiessen C, Wisel SA, Yamaguchi S, Dietch ZC, Feng S, Freise CE| | View in PubMed
  38. Recommended Treatment for Antibody-mediated Rejection After Kidney Transplantation: The 2019 Expert Consensus From the Transplantion Society Working Group.
    Schinstock CA, Mannon RB, Budde K, Chong AS, Haas M, Knechtle S, Lefaucheur C, Montgomery RA, Nickerson P, Tullius SG, Ahn C, Askar M, Crespo M, Chadban SJ, Feng S, Jordan SC, Man K, Mengel M, Morris RE, O'Doherty I, Ozdemir BH, Seron D, Tambur AR, Tanabe K, Taupin JL, O'Connell PJ| | View in PubMed
  39. The molecular diagnosis of rejection in liver transplant biopsies: First results of the INTERLIVER study.
    Madill-Thomsen K, Abouljoud M, Bhati C, Ciszek M, Durlik M, Feng S, Foroncewicz B, Francis I, Grat M, Jurczyk K, Klintmalm G, Krasnodebski M, McCaughan G, Miquel R, Montano-Loza A, Moonka D, Mucha K, Myslak M, Paczek L, Perkowska-Ptasinska A, Piecha G, Reichman T, Sanchez-Fueyo A, Tronina O, Wawrzynowicz-Syczewska M, Wiecek A, Zieniewicz K, Halloran PF| | View in PubMed
  40. Long-term follow-up of beta cell replacement therapy in 10 HIV-infected patients with renal failure secondary to type 1 diabetes mellitus.
    Roll GR, Posselt AM, Freise J, Baird J, Syed S, Mo Kang S, Hirose R, Szot GL, Zarinsefat A, Feng S, Worner G, Sarwal M, Stock PG| | View in PubMed
  41. IgG4 donor-specific HLA antibody profile is associated with subclinical rejection in stable pediatric liver recipients.
    Jackson AM, Kanaparthi S, Burrell BE, Lucas DP, Vega RM, Demetris AJ, Feng S| | View in PubMed
  42. Prevalence and Impact of De Novo Donor-Specific Antibodies During a Multicenter Immunosuppression Withdrawal Trial in Adult Liver Transplant Recipients.
    Jucaud V, Shaked A, DesMarais M, Sayre P, Feng S, Levitsky J, Everly MJ| | View in PubMed
  43. Posttransplant biopsy risk for stable long-term pediatric liver transplant recipients: 451 percutaneous biopsies from two multicenter immunosuppression withdrawal trials.
    Perito ER, Martinez M, Turmelle YP, Mason K, Spain KM, Bucuvalas JC, Feng S| | View in PubMed
  44. Outcomes of immunosuppression minimization and withdrawal early after liver transplantation.
    Shaked A, DesMarais MR, Kopetskie H, Feng S, Punch JD, Levitsky J, Reyes J, Klintmalm GB, Demetris AJ, Burrell BE, Priore A, Bridges ND, Sayre PH| | View in PubMed
  45. Reply.
    Feng S, Bucuvalas J| | View in PubMed
  46. Liver transplants for noncitizens/nonresidents: What is the problem, and what should be done?
    Rahmel A, Feng S| | View in PubMed
  47. Evidence of Chronic Allograft Injury in Liver Biopsies From Long-term Pediatric Recipients of Liver Transplants.
    Feng S, Bucuvalas JC, Demetris AJ, Burrell BE, Spain KM, Kanaparthi S, Magee JC, Ikle D, Lesniak A, Lozano JJ, Alonso EM, Bray RA, Bridges NE, Doo E, Gebel HM, Gupta NA, Himes RW, Jackson AM, Lobritto SJ, Mazariegos GV, Ng VL, Rand EB, Sherker AH, Sundaram S, Turmelle YP, Sanchez-Fueyo A| | View in PubMed
  48. Sensitization in Transplantation: Assessment of Risk (STAR) 2017 Working Group Meeting Report.
    Tambur AR, Campbell P, Claas FH, Feng S, Gebel HM, Jackson AM, Mannon RB, Reed EF, Tinckam K, Askar M, Chandraker A, Chang PP, Colvin M, Demetris AJ, Diamond JM, Dipchand AI, Fairchild RL, Ford ML, Friedewald J, Gill RG, Glotz D, Goldberg H, Hachem R, Knechtle S, Kobashigawa J, Levine DJ, Levitsky J, Mengel M, Milford E, Newell KA, O'Leary JG, Palmer S, Randhawa P, Smith J, Snyder L, Starling RC, Sweet S, Taner T, Taylor CJ, Woodle S, Zeevi A, Nickerson P| | View in PubMed
  49. Reply.
    Lai JC, Covinsky KE, Dodge JL, Boscardin WJ, Segev DL, Roberts JP, Feng S| | View in PubMed
  50. Physical frailty after liver transplantation.
    Lai JC, Segev DL, McCulloch CE, Covinsky KE, Dodge JL, Feng S| | View in PubMed
  51. The Liver Frailty Index Improves Mortality Prediction of the Subjective Clinician Assessment in Patients With Cirrhosis.
    Lai JC, Covinsky KE, McCulloch CE, Feng S| | View in PubMed
  52. Tolerance after liver transplantation: Where are we?
    Feng S, Bucuvalas J| | View in PubMed
  53. Tolerance in clinical liver transplantation.
    Levitsky J, Feng S| | View in PubMed
  54. Living donor liver transplantation in high Model for End-Stage Liver Disease score patients.
    Feng S| | View in PubMed
  55. Early and Late Factors Impacting Patient and Graft Outcome in Pediatric Liver Transplantation: Summary of an ESPGHAN Monothematic Conference.
    McLin VA, Allen U, Boyer O, Bucuvalas J, Colledan M, Cuturi MC, d'Antiga L, Debray D, Dezsofi A, Goyet JV, Dhawan A, Durmaz O, Falk C, Feng S, Fischler B, Franchi-Abella S, Frauca E, Ganschow R, Gottschalk S, Hadzic N, Hierro L, Horslen S, Hubscher S, Karam V, Kelly D, Maecker-Kolhoff B, Mazariegos G, McKiernan P, Melk A, Nobili V, Ozgenç F, Reding R, Sciveres M, Sharif K, Socha P, Toso C, Vajro P, Verma A, Wildhaber BE, Baumann U| | View in PubMed
  56. Development of a novel frailty index to predict mortality in patients with end-stage liver disease.
    Lai JC, Covinsky KE, Dodge JL, Boscardin WJ, Segev DL, Roberts JP, Feng S| | View in PubMed
  57. Optimizing Graft Survival by Pretreatment of the Donor.
    Feng S| | View in PubMed
  58. Current status of tolerance in kidney transplantation.
    Chandran S, Feng S| | View in PubMed
  59. The questions not the answers: Outcomes after pediatric liver transplantation.
    Bucuvalas JC, Feng S| | View in PubMed
  60. A Comparison of Muscle Function, Mass, and Quality in Liver Transplant Candidates: Results From the Functional Assessment in Liver Transplantation Study.
    Wang CW, Feng S, Covinsky KE, Hayssen H, Zhou LQ, Yeh BM, Lai JC| | View in PubMed
  61. Five-year histological and serological follow-up of operationally tolerant pediatric liver transplant recipients enrolled in WISP-R.
    Feng S, Demetris AJ, Spain KM, Kanaparthi S, Burrell BE, Ekong UD, Alonso EM, Rosenthal P, Turka LA, Ikle D, Tchao NK| | View in PubMed
  62. Response to clinical assessments of health status as a potential marker to identify patients who are too sick to undergo transplantation.
    Lai JC, Covinsky KE, Hayssen H, Lizaola B, Dodge J, Roberts JP, Terrault NA, Feng S| | View in PubMed
  63. Spontaneous and induced tolerance for liver transplant recipients.
    Feng S| | View in PubMed
  64. Functional decline in patients with cirrhosis awaiting liver transplantation: Results from the functional assessment in liver transplantation (FrAILT) study.
    Lai JC, Dodge JL, Sen S, Covinsky K, Feng S| | View in PubMed
  65. Functional impairment in older liver transplantation candidates: From the functional assessment in liver transplantation study.
    Wang CW, Covinsky KE, Feng S, Hayssen H, Segev DL, Lai JC| | View in PubMed
  66. Peripheral phenotype and gene expression profiles of combined liver-kidney transplant patients.
    Dumontet E, Danger R, Vagefi PA, Londoño MC, Pallier A, Lozano JJ, Giral M, Degauque N, Soulillou JP, Martínez-Llordella M, Lee H, Latournerie M, Boudjema K, Dulong J, Tarte K, Sanchez-Fueyo A, Feng S, Brouard S, Conchon S| | View in PubMed
  67. The corrected donor age for hepatitis C virus-infected liver transplant recipients.
    Dirchwolf M, Dodge JL, Gralla J, Bambha KM, Nydam T, Hung KW, Rosen HR, Feng S, Terrault NA, Biggins SW| | View in PubMed
  68. Clinician assessments of health status predict mortality in patients with end-stage liver disease awaiting liver transplantation.
    Lai JC, Covinsky KE, Hayssen H, Lizaola B, Dodge JL, Roberts JP, Terrault NA, Feng S| | View in PubMed
  69. Renal outcomes of simultaneous liver-kidney transplantation compared to liver transplant alone for candidates with renal dysfunction.
    Brennan TV, Lunsford KE, Vagefi PA, Bostrom A, Ma M, Feng S| | View in PubMed
  70. Combined effects of recipient age and model for end-stage liver disease score on liver transplantation outcomes.
    Sharpton SR, Feng S, Hameed B, Yao F, Lai JC| | View in PubMed
  71. Expanded criteria donors.
    Feng S, Lai JC| | View in PubMed
  72. Multiple listings as a reflection of geographic disparity in liver transplantation.
    Vagefi PA, Feng S, Dodge JL, Markmann JF, Roberts JP| | View in PubMed
  73. Evaluation for liver transplantation in adults: 2013 practice guideline by the American Association for the Study of Liver Diseases and the American Society of Transplantation.
    Martin P, DiMartini A, Feng S, Brown R, Fallon M| | View in PubMed
  74. Donor Risk Index for African American liver transplant recipients with hepatitis C virus.
    Shores NJ, Dodge JL, Feng S, Terrault NA| | View in PubMed
  75. Peri-operative hyperglycemia is associated with delayed graft function in deceased donor renal transplantation.
    Parekh J, Roll GR, Feng S, Niemann CU, Hirose R| | View in PubMed
  76. Offer patterns of nationally placed livers by donation service area.
    Lai JC, Feng S, Vittinghoff E, Roberts JP| | View in PubMed
  77. An examination of liver offers to candidates on the liver transplant wait-list.
    Lai JC, Feng S, Roberts JP| | View in PubMed
  78. Increasing disparity in waitlist mortality rates with increased model for end-stage liver disease scores for candidates with hepatocellular carcinoma versus candidates without hepatocellular carcinoma.
    Goldberg D, French B, Abt P, Feng S, Cameron AM| | View in PubMed
  79. Complete immunosuppression withdrawal and subsequent allograft function among pediatric recipients of parental living donor liver transplants.
    Feng S, Ekong UD, Lobritto SJ, Demetris AJ, Roberts JP, Rosenthal P, Alonso EM, Philogene MC, Ikle D, Poole KM, Bridges ND, Turka LA, Tchao NK| | View in PubMed
  80. KIR genotypic diversity can track ancestries in heterogeneous populations: a potential confounder for disease association studies.
    Singh KM, Phung YT, Kohla MS, Lan BY, Chan S, Suen DL, Murad S, Rheault S, Davidson P, Evans J, Singh M, Dohil S, Osorio RW, Wakil AE, Page K, Feng S, Cooper SL| | View in PubMed
  81. Kidney transplant performed after liver transplant: a single center experience.
    Levine MH, Parekh J, Feng S, Freise C| | View in PubMed
  82. Preface: Optimization of outcomes for children after solid organ transplantation.
    Ng VL, Feng S| | View in PubMed
  83. Tolerance: is it achievable in pediatric solid organ transplantation?
    Seyfert-Margolis V, Feng S| | View in PubMed
  84. Management of the liver transplant patient.
    Gelb B, Feng S| | View in PubMed
  85. Factors influencing liver transplant length of stay at two large-volume transplant centers.
    Washburn WK, Meo NA, Halff GA, Roberts JP, Feng S| | View in PubMed
  86. Report of the first international liver transplantation society expert panel consensus conference on renal insufficiency in liver transplantation.
    Charlton MR, Wall WJ, Ojo AO, Ginès P, Textor S, Shihab FS, Marotta P, Cantarovich M, Eason JD, Wiesner RH, Ramsay MA, Garcia-Valdecasas JC, Neuberger JM, Feng S, Davis CL, Gonwa TA, International Liver Transplantation Society Expert Panel| | View in PubMed
  87. Increased donor risk: who should bear the burden?
    Feng S| | View in PubMed
  88. Long-term histological effects of preemptive antiviral therapy in liver transplant recipients with hepatitis C virus infection.
    Kuo A, Tan V, Lan B, Khalili M, Feng S, Roberts JP, Terrault NA| | View in PubMed
  89. Long-term management of immunosuppression after pediatric liver transplantation: is minimization or withdrawal desirable or possible or both?
    Feng S| | View in PubMed
  90. Excellent outcome following down-staging of hepatocellular carcinoma prior to liver transplantation: an intention-to-treat analysis.
    Yao FY, Kerlan RK, Hirose R, Davern TJ, Bass NM, Feng S, Peters M, Terrault N, Freise CE, Ascher NL, Roberts JP| | View in PubMed
  91. Steatotic livers for liver transplantation--life-saving but at a cost.
    Feng S| | View in PubMed
  92. Allocation policy for hepatocellular carcinoma in the MELD era: room for improvement?
    Roayaie K, Feng S| | View in PubMed
  93. Linking the US transplant registry to administrative claims data: expanding the potential of transplant research.
    Gilmore AS, Helderman JH, Ricci JF, Ryskina KL, Feng S, Kang N, Legorreta AP| | View in PubMed
  94. Liver-specific loss of beta-catenin results in delayed hepatocyte proliferation after partial hepatectomy.
    Sekine S, Gutiérrez PJ, Lan BY, Feng S, Hebrok M| | View in PubMed
  95. In a MELD-based economy, how can we fight off inflation?
    Biggins SW, Feng S| | View in PubMed
  96. Optimizing living donor kidney graft function by donor-recipient pair selection.
    Brennan TV, Bostrom A, Feng S| | View in PubMed
  97. Magnetic resonance imaging of hepatocellular carcinoma mimicking focal nodular hyperplasia: a potential pitfall in patients with cirrhosis?
    Rafaelian O, Coakley FV, Qayyum A, Breiman RS, Yeh BM, Joe BN, Westphalen AC, Feng S| | View in PubMed
  98. How can we define expanded criteria for liver donors?
    Merion RM, Goodrich NP, Feng S| | View in PubMed
  99. Effect of mycophenolate mofetil on rat kidney grafts with prolonged cold preservation.
    Fuller TF, Hoff U, Rose F, Linde Y, Freise CE, Dragun D, Feng S| | View in PubMed
  100. Liver-specific loss of beta-catenin blocks glutamine synthesis pathway activity and cytochrome p450 expression in mice.
    Sekine S, Lan BY, Bedolli M, Feng S, Hebrok M| | View in PubMed
  101. Trends over a decade of pediatric liver transplantation in the United States.
    Feng S, Si M, Taranto SE, McBride MA, Mudge C, Stritzel S, Roberts JP, Rosenthal P| | View in PubMed
  102. A prospective study on downstaging of hepatocellular carcinoma prior to liver transplantation.
    Yao FY, Hirose R, LaBerge JM, Davern TJ, Bass NM, Kerlan RK, Merriman R, Feng S, Freise CE, Ascher NL, Roberts JP| | View in PubMed
  103. End stage polycystic kidney disease: indications and timing of native nephrectomy relative to kidney transplantation.
    Fuller TF, Brennan TV, Feng S, Kang SM, Stock PG, Freise CE| | View in PubMed
  104. Expanded criteria donor kidney allocation: marked decrease in cold ischemia and delayed graft function at a single center.
    Carter JT, Chan S, Roberts JP, Feng S| | View in PubMed
  105. Selecting livers for transplantation: can beggars be choosers?
    Feng S| | View in PubMed
  106. PELD: working well, but only half of the time?
    Magee JC, Feng S| | View in PubMed
  107. Laparoscopic procurement of kidneys with multiple renal arteries is associated with increased ureteral complications in the recipient.
    Carter JT, Freise CE, McTaggart RA, Mahanty HD, Kang SM, Chan SH, Feng S, Roberts JP, Posselt AM| | View in PubMed
  108. Impact of sirolimus on early graft function after deceased-donor kidney transplantation.
    McTaggart RA, Tomlanovich SJ, Feng S| | View in PubMed
  109. An older liver in the hand, or a (possibly) younger liver in the bush?
    Feng S, Roberts J| | View in PubMed
  110. Surgical challenges in transplantation: the Fourth Annual American Society of Transplant Surgeons' State-of-the-Art Winter Symposium.
    Feng S, Humar A, Pomfret E, Fishbein T, Gaber O| | View in PubMed
  111. BKV in simultaneous pancreas-kidney transplant recipients: a leading cause of renal graft loss in first 2 years post-transplant.
    Lipshutz GS, Mahanty H, Feng S, Hirose R, Stock PG, Kang SM, Posselt AM, Freise CE| | View in PubMed
  112. Transplantation of islets transduced with CTLA4-Ig and TGFbeta using adenovirus and lentivirus vectors.
    Fernandes JR, Duvivier-Kali VF, Keegan M, Hollister-Lock J, Omer A, Su S, Bonner-Weir S, Feng S, Lee JS, Mulligan RC, Weir GC| | View in PubMed
  113. Increased rejection in living unrelated versus living related kidney transplants does not affect short-term function and survival.
    Fuller TF, Feng S, Brennan TV, Tomlanovich S, Bostrom A, Freise CE| | View in PubMed
  114. Developmental context determines latency of MYC-induced tumorigenesis.
    Beer S, Zetterberg A, Ihrie RA, McTaggart RA, Yang Q, Bradon N, Arvanitis C, Attardi LD, Feng S, Ruebner B, Cardiff RD, Felsher DW| | View in PubMed
  115. Comparison of outcomes after delayed graft function: sirolimus-based versus other calcineurin-inhibitor sparing induction immunosuppression regimens.
    McTaggart RA, Tomlanovich S, Bostrom A, Roberts JP, Feng S| | View in PubMed
  116. Hepatitis C etiology of liver disease is strongly associated with early acute rejection following liver transplantation.
    McTaggart RA, Terrault NA, Vardanian AJ, Bostrom A, Feng S| | View in PubMed
  117. National conference to assess antibody-mediated rejection in solid organ transplantation.
    Takemoto SK, Zeevi A, Feng S, Colvin RB, Jordan S, Kobashigawa J, Kupiec-Weglinski J, Matas A, Montgomery RA, Nickerson P, Platt JL, Rabb H, Thistlethwaite R, Tyan D, Delmonico FL| | View in PubMed
  118. Early graft function after living donor kidney transplantation predicts rejection but not outcomes.
    Brennan TV, Freise CE, Fuller TF, Bostrom A, Tomlanovich SJ, Feng S| | View in PubMed
  119. An uncomfortable silence em leader while we all search for a better reporter gene in adult stem cell biology.
    McTaggart RA, Feng S| | View in PubMed
  120. Organ donors with malignant gliomas: an update.
    Collignon FP, Holland EC, Feng S| | View in PubMed
  121. Sirolimus delays recovery of rat kidney transplants after ischemia-reperfusion injury.
    Fuller TF, Freise CE, Serkova N, Niemann CU, Olson JL, Feng S| | View in PubMed
  122. Tumors and transplantation: The 2003 Third Annual ASTS State-of-the-Art Winter Symposium.
    Feng S, Buell JF, Chari RS, DiMaio JM, Hanto DW| | View in PubMed
  123. Death from donor-transmitted malignancy despite emergency liver retransplantation.
    Lipshutz GS, Baxter-Lowe LA, Nguyen T, Jones KD, Ascher NL, Feng S| | View in PubMed
  124. Excellent short-term results with steroid-free maintenance immunosuppression in low-risk simultaneous pancreas-kidney transplantation.
    Freise CE, Kang SM, Feng S, Hirose R, Stock P| | View in PubMed
  125. Management of lymphoceles after renal transplantation: laparoscopic versus open drainage.
    Fuller TF, Kang SM, Hirose R, Feng S, Stock PG, Freise CE| | View in PubMed
  126. Sirolimus prolongs recovery from delayed graft function after cadaveric renal transplantation.
    McTaggart RA, Gottlieb D, Brooks J, Bacchetti P, Roberts JP, Tomlanovich S, Feng S| | View in PubMed
  127. Expanded criteria donors for kidney transplantation.
    Metzger RA, Delmonico FL, Feng S, Port FK, Wynn JJ, Merion RM| | View in PubMed
  128. Organ donors with positive viral serology or malignancy: risk of disease transmission by transplantation.
    Feng S, Buell JF, Cherikh WS, Deng MC, Hanto DW, Kauffman HM, Leichtman AB, Lorber MI, Maters RG, McBride MA, Metzger RA, Nolte FS, O'Connor KJ, Roth D, Terrault NA, Henry ML| | View in PubMed
  129. Report of the Crystal City meeting to maximize the use of organs recovered from the cadaver donor.
    Rosengard BR, Feng S, Alfrey EJ, Zaroff JG, Emond JC, Henry ML, Garrity ER, Roberts JP, Wynn JJ, Metzger RA, Freeman RB, Port FK, Merion RM, Love RB, Busuttil RW, Delmonico FL| | View in PubMed
  130. Targeted gene therapy with CD40Ig to induce long-term acceptance of liver allografts.
    Chang GJ, Liu T, Feng S, Bedolli M, O'rourke RW, Schmidt G, Roberts JP, Stock PG| | View in PubMed
  131. HIV-1 tat trans-activation requires the loop sequence within tar.
    Feng S, Holland EC| | View in PubMed